MolNFT v1 · #160680 · protein
HIV-1 protease multiple drug resistant clinical isolate mutant PR20 with grl-14213A
6PRF: “HIV-1 protease multiple drug resistant clinical isolate mutant PR20 with grl-14213A”. X-ray diffraction, 2 ligands (7OA, Y1). MolNFT v1 #160680 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6PRF
- Type
- protein
- Length
- 198 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P03366
- Ligands
- 7OA, Y1
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | — | protein | 99 | — | P03366 |
Ligands and binding sites
- 7OA · (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate · ligand · chains A, B
- Y1 · Yttrium ion · metal · 9 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 6PRF · HIV-1 Protease multiple drug resistant clinical isolate mutant PR20 with GRL-14213A · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P03366
- Elsewhere: RCSB PDB 6PRF · PDBe 6PRF · UniProt P03366
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.